Legal Representation
Attorney
Carrie Webb Olson, Esq.
USPTO Deadlines
Application History
21 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jul 5, 2011 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jul 5, 2011 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | Loading... |
| Nov 30, 2010 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Oct 5, 2010 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Oct 5, 2010 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 28, 2010 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Aug 26, 2010 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Aug 17, 2010 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Aug 17, 2010 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 17, 2010 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 2, 2010 | PROA | I | TEAS PETITION TO REVIVE RECEIVED | Loading... |
| Aug 2, 2010 | PETG | O | PETITION TO REVIVE-GRANTED | Loading... |
| Aug 2, 2010 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jun 3, 2010 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Jun 3, 2010 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
| Oct 15, 2009 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Oct 15, 2009 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Oct 15, 2009 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Oct 14, 2009 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 17, 2009 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
| Jul 17, 2009 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Detailed Classifications
Class 005
pharmaceuticals and medicinal preparations for the treatment of inflammatory diseases and disorders, cancer, anticoagulation and use as antithrombotics; veterinary preparations for the treatment of inflammatory diseases and disorders and cancer; regenerative pharmaceutical and medicinal preparations including stem cell applications; veterinary regenerative pharmaceutical and medicinal preparations including stem cell applications, anticoagulation and use as thrombotics
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005